Methylated immunostimulatory oligonucleotides and methods of using the same

Details for Australian Patent Application No. 2003229433 (hide)

International Classifications

Event Publications

14 August 2003 Complete Application Filed

Priority application(s): 60/379,343 10.05.02 US; 60/460,646 04.04.03 US; 10/290,545 07.11.02 US

15 January 2004 Application Open to Public Inspection

Published as AU-B-2003229433

10 January 2008 Assignment before Grant

Inex Pharmaceuticals Corporation The application has been assigned to Tekmira Pharmaceuticals Corporation

24 April 2008 Application Accepted

Published as AU-B-2003229433

21 August 2008 Standard Patent Sealed

2 July 2009 Corrigenda

Applications OPI - Name Index Under the Name Tekmira Pharmaceuticals Corporation, Application No. 2003229433, under INID (43) correct the date to 24 November 2003 Corrigenda

10 December 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.